Form: 10-K

Annual report pursuant to Section 13 and 15(d)

June 21, 2024

Exhibit 21.1

Acasti Pharma Inc.

LIST OF SUBSIDIARIES

Name

Jurisdiction of Incorporation

Percent Owned

Acasti Pharma U.S., Inc.

New Jersey, United States

100%